Eyepod Bayer

Welcome to EyePod Bayer!In this episode, we interview some of our speakers on the evenening meeting in Copenhagen the 5th of December.Professor Justus Garweg from Bern in Switzerland speaks about pros and cons of long term treatment with anti-VEGF.Anna Stage Vergmann from Odense Universitetshospital speaks about OCT-A as a new way of assessing neovascularizations in proliferative diabetic retinopathy. Mads Forslund Jacobsen from Rigshospitalet/Glostrup speaks about Robot-assisted vitreoretinal surgery.Welcome!eyepod@bayer.com MA-EYL-DK-0101-1  Hosted on Acast. See acast.com/privacy for more information.